Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(20)30990-7
PubMed Identifier: 33484647
Publication URI: http://europepmc.org/abstract/MED/33484647
Type: Journal Article/Review
Volume: 21
Parent Publication: The Lancet. Infectious diseases
Issue: 5
ISSN: 1473-3099